We demonstrated that CHI3L1 showed higher AUC values compared to others in the ROC analysis using serum of AD patients and healthy controls, presenting the possibility that CHI3L1 could be used as one of the biomarkers for AD diagnosis. Here, CHI3L1 is linked to Alzheimer disease.